LITERATURE · PEER REVIEWED

Mutations in ASH1L confer susceptibility to Tourette syndrome

Molecular Psychiatry · 2020 · Peer reviewed

COMPLETE CITATION

Citation and identifiers

Liu S, Tian M, He F, et al.. “Mutations in ASH1L confer susceptibility to Tourette syndrome.” Molecular Psychiatry. 25(2):476–490 · doi:10.1038/s41380-019-0560-8.

PubMed ID
31673123

RESEARCH QUESTION

Do human genetic and functional data support ASH1L as a susceptibility gene for Tourette syndrome?

The study addresses Tourette-syndrome susceptibility using human and follow-up model evidence, an ascertainment context distinct from ASH1L haploinsufficiency-related neurodevelopmental disorder.

INTERPRETATION BOUNDARY

Read the finding and limit together.

What this study supports

Human genetic analysis with functional and animal-model follow-up supporting ASH1L as a Tourette-susceptibility gene.

What it cannot establish

Tourette-susceptibility findings are a distinct ascertainment and disease context from ASH1L haploinsufficiency-related NDD.

OPEN THE STUDY